Simvastatin in Waldenstrom's Macroglobulinemia

NCT00575965 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

18

Enrollment

OTHER

Sponsor class

Stopped Slow accrual led to early study termination.

Conditions

Waldenstrom's Macroglobulinemia

Interventions

DRUG: Simvastatin

Sponsor

Dana-Farber Cancer Institute